The primary objective of your trial was to find out if Anastrozole could lengthen the period of “disease-absolutely free survival” for the participating patients. Ailment-absolutely free survival is described as being the period after medications and/or treatments are stopped ahead of the patient’s cancer returns. In the course of the demo, r